21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46 - Wholesale trade
47 - Retail trade
71.20.B - Inspection and issuing opinions on the technical condition of chimneys and ventilation ducts
72.11.Z - Scientific research and development activities
72.19.Z - Scientific research and development activities
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -1,5 | -2,5 | -4,2 | -70,2 |
EBITDA | -1,5 | -2,4 | -4,1 | -69 |
Short time liabilities | 0,4 | 0,3 | 0,5 | 84,2 |
Equity capital | 0,1 | 2,5 | 2,3 | -8,2 |
Operating profit (EBIT) | -1,5 | -2,5 | -4,2 | -69,7 |
Assets | 0,6 | 2,8 | 2,9 | 1,5 |
Net profit (loss) | -1,5 | -2,5 | -4,2 | -70,2 |
Cash | 0,1 | 0,4 | 1,2 | 228,1 |
Liabilities and provisions for liabilities | 0,5 | 0,4 | 0,6 | 62,7 |
Net income from sale | 0,7 | 1 | 1,4 | 32,9 |
Working assets | 0,4 | 0,9 | 2,2 | 146,2 |
Depreciation | 0 | 0,1 | 0,2 | 89,6 |
% | % | % | p.p. | |
Profitability of capital | -1230 | -100,5 | -186,3 | -85,8 |
Equity capital to total assets | 20,2 | 86,4 | 78,2 | -8,2 |
Gross profit margin | -216,4 | -239,9 | -307,4 | -67,5 |
EBITDA Margin | -210,3 | -233,7 | -297,3 | -63,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 205 | 103 | 142 | 39 |
Current financial liquidity indicator | 0.727183997631073 | 2.4652068614959717 | 4.013388156890869 | 1,5 |
Net dept to EBITDA | 0.08753246814012527 | 0.14880195260047913 | 0.2888491153717041 | 0,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane